Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Development of renal failure in PargParp-1 null and Timm23 hypomorphic mice.

Chen L, Gunji A, Uemura A, Fujihara H, Nakamoto K, Onodera T, Sasaki Y, Imamichi S, Isumi M, Nozaki T, Kamada N, Jishage KI, Masutani M.

Biochem Pharmacol. 2019 Jul 19. pii: S0006-2952(19)30258-8. doi: 10.1016/j.bcp.2019.07.003. [Epub ahead of print]

PMID:
31326434
2.

Dysfunction of Poly (ADP-Ribose) Glycohydrolase Induces a Synthetic Lethal Effect in Dual Specificity Phosphatase 22-Deficient Lung Cancer Cells.

Sasaki Y, Fujimori H, Hozumi M, Onodera T, Nozaki T, Murakami Y, Ashizawa K, Inoue K, Koizumi F, Masutani M.

Cancer Res. 2019 Aug 1;79(15):3851-3861. doi: 10.1158/0008-5472.CAN-18-1037. Epub 2019 May 29.

PMID:
31142510
3.

Aberrations in DNA repair pathways in cancer and therapeutic significances.

Motegi A, Masutani M, Yoshioka KI, Bessho T.

Semin Cancer Biol. 2019 Mar 25. pii: S1044-579X(18)30089-0. doi: 10.1016/j.semcancer.2019.02.005. [Epub ahead of print] Review.

PMID:
30922960
4.

Dependence of neutrons generated by 7Li(p,n) reaction on Li thickness under free-air condition in accelerator-based boron neutron capture therapy system employing solid-state Li target.

Nakamura S, Igaki H, Okamoto H, Wakita A, Ito M, Imamichi S, Nishioka S, Iijima K, Nakayama H, Takemori M, Kobayashi K, Abe Y, Okuma K, Takahashi K, Inaba K, Murakami N, Nakayama Y, Nishio T, Masutani M, Itami J.

Phys Med. 2019 Feb;58:121-130. doi: 10.1016/j.ejmp.2019.02.010. Epub 2019 Feb 16.

PMID:
30824143
5.

Expression of phosphatase and tensin homolog and programmed cell death ligand 1 in adenosquamous carcinoma of the lung.

Hlaing AM, Furusato B, Udo E, Kitamura Y, Souda M, Masutani M, Fukuoka J.

Biochem Biophys Res Commun. 2018 Sep 18;503(4):2764-2769. doi: 10.1016/j.bbrc.2018.08.037. Epub 2018 Aug 9.

PMID:
30100056
6.

Concomitant administration of radiation with eribulin improves the survival of mice harboring intracerebral glioblastoma.

Miki S, Imamichi S, Fujimori H, Tomiyama A, Fujimoto K, Satomi K, Matsushita Y, Matsuzaki S, Takahashi M, Ishikawa E, Yamamoto T, Matsumura A, Mukasa A, Nishikawa R, Masutomi K, Narita Y, Masutani M, Ichimura K.

Cancer Sci. 2018 Jul;109(7):2275-2285. doi: 10.1111/cas.13637. Epub 2018 Jun 19.

7.

Next-generation sequencing-based miRNA expression analysis in Parp1-deficient embryonic stem cell-derived exosomes.

Nozaki T, Sasaki Y, Fukuda I, Isumi M, Nakamoto K, Onodera T, Masutani M.

Biochem Biophys Res Commun. 2018 May 15;499(3):410-415. doi: 10.1016/j.bbrc.2018.03.073. Epub 2018 Mar 22.

PMID:
29534966
8.

Evaluation of radioactivity in the bodies of mice induced by neutron exposure from an epi-thermal neutron source of an accelerator-based boron neutron capture therapy system.

Nakamura S, Imamichi S, Masumoto K, Ito M, Wakita A, Okamoto H, Nishioka S, Iijima K, Kobayashi K, Abe Y, Igaki H, Kurita K, Nishio T, Masutani M, Itami J.

Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(10):821-831. doi: 10.2183/pjab.93.051.

9.

Poly (ADP-ribose) polymerase inhibitors selectively induce cytotoxicity in TCF3-HLF-positive leukemic cells.

Piao J, Takai S, Kamiya T, Inukai T, Sugita K, Ohyashiki K, Delia D, Masutani M, Mizutani S, Takagi M.

Cancer Lett. 2017 Feb 1;386:131-140. doi: 10.1016/j.canlet.2016.11.021. Epub 2016 Nov 25.

PMID:
27894958
10.

Regression of gastric de novo diffuse large B-cell lymphoma following Helicobacter pylori eradication: a case report.

Saito M, Masutani M, Mabe K, Izumiyama K, Mori A, Irie T, Tanaka M, Morioka M, Tanino M.

Acta Gastroenterol Belg. 2016 Jul-Sep;79(3):367-369.

PMID:
27821034
11.

PARG Inhibitors and Functional PARG Inhibition Models.

Sasaki Y, Hozumi M, Fujimori H, Murakami Y, Koizumi F, Inoue K, Masutani M.

Curr Protein Pept Sci. 2016;17(7):641-653.

PMID:
27817742
12.

Parp1 Deficiency Confers Defects in Chromatin Surveillance and Remodeling During Reprogramming by Nuclear Transfer.

Osada T, Nozaki T, Masutani M.

Curr Protein Pept Sci. 2016;17(7):693-704.

PMID:
27090907
13.

Radiosensitization by PARP inhibition to proton beam irradiation in cancer cells.

Hirai T, Saito S, Fujimori H, Matsushita K, Nishio T, Okayasu R, Masutani M.

Biochem Biophys Res Commun. 2016 Sep 9;478(1):234-240. doi: 10.1016/j.bbrc.2016.07.062. Epub 2016 Jul 15.

PMID:
27425251
14.

A Prospective Multicenter Study Using a Virtual 3 Fr Percutaneous Coronary Intervention System: The V3 Registry.

Yoshimachi F, Takagawa Y, Terai H, Takahashi A, Shimada Y, Katsuki T, Tohara S, Ueno H, Takada M, Shiode N, Yamada K, Kinoshita N, Honda T, Asano H, Takeshita S, Koiwa H, Shin T, Masutani M, Matsukage T, Saito S, Ikari Y; The V3 Registry Investigators.

J Invasive Cardiol. 2017 Jan;29(1):16-23. Epub 2016 Jun 15.

15.

MicroRNA-351 Regulates Two-Types of Cell Death, Necrosis and Apoptosis, Induced by 5-fluoro-2'-deoxyuridine.

Sato A, Omi T, Yamamoto A, Satake A, Hiramoto A, Masutani M, Tanuma S, Wataya Y, Kim HS.

PLoS One. 2016 Apr 12;11(4):e0153130. doi: 10.1371/journal.pone.0153130. eCollection 2016.

16.

Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in Vivo.

Yasukawa M, Fujihara H, Fujimori H, Kawaguchi K, Yamada H, Nakayama R, Yamamoto N, Kishi Y, Hamada Y, Masutani M.

Int J Mol Sci. 2016 Feb 24;17(3):272. doi: 10.3390/ijms17030272.

17.

Loss of CtIP disturbs homologous recombination repair and sensitizes breast cancer cells to PARP inhibitors.

Wang J, Ding Q, Fujimori H, Motegi A, Miki Y, Masutani M.

Oncotarget. 2016 Feb 16;7(7):7701-14. doi: 10.18632/oncotarget.6715.

18.

A comprehensive analysis of radiosensitization targets; functional inhibition of DNA methyltransferase 3B radiosensitizes by disrupting DNA damage regulation.

Fujimori H, Sato A, Kikuhara S, Wang J, Hirai T, Sasaki Y, Murakami Y, Okayasu R, Masutani M.

Sci Rep. 2015 Dec 15;5:18231. doi: 10.1038/srep18231.

19.

PARP Inhibitor PJ34 Suppresses Osteogenic Differentiation in Mouse Mesenchymal Stem Cells by Modulating BMP-2 Signaling Pathway.

Kishi Y, Fujihara H, Kawaguchi K, Yamada H, Nakayama R, Yamamoto N, Fujihara Y, Hamada Y, Satomura K, Masutani M.

Int J Mol Sci. 2015 Oct 19;16(10):24820-38. doi: 10.3390/ijms161024820.

20.

Proteomic analysis of cellular response induced by boron neutron capture reaction in human squamous cell carcinoma SAS cells.

Sato A, Itoh T, Imamichi S, Kikuhara S, Fujimori H, Hirai T, Saito S, Sakurai Y, Tanaka H, Nakamura H, Suzuki M, Murakami Y, Baiseitov D, Berikkhanova K, Zhumadilov Z, Imahori Y, Itami J, Ono K, Masunaga S, Masutani M.

Appl Radiat Isot. 2015 Dec;106:213-9. doi: 10.1016/j.apradiso.2015.08.001. Epub 2015 Aug 12.

PMID:
26302661
21.

Safety and feasibility of the new 5 Fr Glidesheath Slender.

Yoshimachi F, Kiemeneij F, Masutani M, Matsukage T, Takahashi A, Ikari Y.

Cardiovasc Interv Ther. 2016 Jan;31(1):38-41. doi: 10.1007/s12928-015-0344-2. Epub 2015 Jul 4.

22.

A translation system reconstituted with human factors proves that processing of encephalomyocarditis virus proteins 2A and 2B occurs in the elongation phase of translation without eukaryotic release factors.

Machida K, Mikami S, Masutani M, Mishima K, Kobayashi T, Imataka H.

J Biol Chem. 2014 Nov 14;289(46):31960-71. doi: 10.1074/jbc.M114.593343. Epub 2014 Sep 25.

23.

Design and synthesis of phenolic hydrazide hydrazones as potent poly(ADP-ribose) glycohydrolase (PARG) inhibitors.

Islam R, Koizumi F, Kodera Y, Inoue K, Okawara T, Masutani M.

Bioorg Med Chem Lett. 2014 Aug 15;24(16):3802-6. doi: 10.1016/j.bmcl.2014.06.065. Epub 2014 Jun 27.

PMID:
25042255
24.

ADP-ribosyltransferases Parp1 and Parp7 safeguard pluripotency of ES cells.

Roper SJ, Chrysanthou S, Senner CE, Sienerth A, Gnan S, Murray A, Masutani M, Latos P, Hemberger M.

Nucleic Acids Res. 2014 Aug;42(14):8914-27. doi: 10.1093/nar/gku591. Epub 2014 Jul 17.

25.

Response to letter regarding article, "Thermodilution-derived coronary blood flow pattern immediately after coronary intervention as a predictor of microcirculatory damage and midterm clinical outcomes in patients with ST-segment-elevation myocardial infarction".

Fukunaga M, Fujii K, Kawasaki D, Sawada H, Miki K, Tamaru H, Imanaka T, Iwasaku T, Nakata T, Shibuya M, Akahori H, Masutani M, Kobayashi K, Ohyanagi M, Masuyama T.

Circ Cardiovasc Interv. 2014 Jun;7(3):418. doi: 10.1161/CIRCINTERVENTIONS.114.001589. No abstract available.

PMID:
24944307
26.

Potential influence of invisible coronary collateral circulation on fractional flow reserve of donor artery in the presence of severe stenosis of receiving artery.

Tamaru H, Fujii K, Fukunaga M, Imanaka T, Miki K, Kawasaki D, Masutani M, Ohyanagi M, Masuyama T.

Cardiovasc Interv Ther. 2015 Jul;30(3):266-9. doi: 10.1007/s12928-014-0275-3. Epub 2014 Jun 13.

PMID:
24923579
27.

Gastrointestinal symptoms and food/nutrition concerns after the great East Japan earthquake in March 2011: survey of evacuees in a temporary shelter.

Inoue T, Nakao A, Kuboyama K, Hashimoto A, Masutani M, Ueda T, Kotani J.

Prehosp Disaster Med. 2014 Jun;29(3):303-6. doi: 10.1017/S1049023X14000533. Epub 2014 Jun 6.

PMID:
24905001
28.

Elastic cartilage reconstruction by transplantation of cultured hyaline cartilage-derived chondrocytes.

Mizuno M, Takebe T, Kobayashi S, Kimura S, Masutani M, Lee S, Jo YH, Lee JI, Taniguchi H.

Transplant Proc. 2014 May;46(4):1217-21. doi: 10.1016/j.transproceed.2013.12.006.

PMID:
24815164
29.

Comparison of frequency of radial artery occlusion after 4Fr versus 6Fr transradial coronary intervention (from the Novel Angioplasty USIng Coronary Accessor Trial).

Takeshita S, Asano H, Hata T, Hibi K, Ikari Y, Kan Y, Katsuki T, Kawasaki T, Masutani M, Matsumura T, Premchand RK, Rao SP, Suzuki T, Takahashi A, Takeda R, Tanaka S, Yamazaki S, Yin WH, Yoshimachi F, Saito S; NAUSICA Trial Investigators.

Am J Cardiol. 2014 Jun 15;113(12):1986-9. doi: 10.1016/j.amjcard.2014.03.040. Epub 2014 Apr 1.

PMID:
24786357
30.

Effect of bare-metal nitinol stent implantation and paclitaxel-eluting nitinol stent implantation on vascular response in the superficial femoral artery lesion assessed on intravascular ultrasound.

Miki K, Fujii K, Kawasaki D, Fukunaga M, Nishimura M, Horimatsu T, Saita T, Tamaru H, Imanaka T, Shibuya M, Masutani M, Ohyanagi M, Masuyama T.

Circ J. 2014;78(6):1451-8. Epub 2014 Apr 9.

31.

Histological and biochemical analysis of DNA damage after BNCT in rat model.

Masutani M, Baiseitov D, Itoh T, Hirai T, Berikkhanova K, Murakami Y, Zhumadilov Z, Imahori Y, Hoshi M, Itami J.

Appl Radiat Isot. 2014 Jun;88:104-8. doi: 10.1016/j.apradiso.2014.03.003. Epub 2014 Mar 12.

PMID:
24690552
32.

Thermodilution-derived coronary blood flow pattern immediately after coronary intervention as a predictor of microcirculatory damage and midterm clinical outcomes in patients with ST-segment-elevation myocardial infarction.

Fukunaga M, Fujii K, Kawasaki D, Sawada H, Miki K, Tamaru H, Imanaka T, Iwasaku T, Nakata T, Shibuya M, Akahori H, Masutani M, Kobayashi K, Ohyanagi M, Masuyama T.

Circ Cardiovasc Interv. 2014 Apr;7(2):149-55. doi: 10.1161/CIRCINTERVENTIONS.113.000505. Epub 2014 Feb 18.

PMID:
24550440
33.

Role of activating transcription factor 3 protein ATF3 in necrosis and apoptosis induced by 5-fluoro-2'-deoxyuridine.

Sato A, Nakama K, Watanabe H, Satake A, Yamamoto A, Omi T, Hiramoto A, Masutani M, Wataya Y, Kim HS.

FEBS J. 2014 Apr;281(7):1892-900. doi: 10.1111/febs.12752. Epub 2014 Mar 6.

34.

A case of acute thrombotic occlusion of the popliteal artery occurring immediately after the total knee arthroplasty recanalized by ballooning alone.

Imanaka T, Fujii K, Fukunaga M, Miki K, Kawasaki D, Tamaru H, Masutani M, Ohyanagi M, Masuyama T.

J Cardiol Cases. 2013 Oct 29;8(6):190-192. doi: 10.1016/j.jccase.2013.08.008. eCollection 2013 Dec.

35.

Parp-1 deficiency in ES cells promotes invasive and metastatic lesions accompanying induction of trophoblast giant cells during tumorigenesis in uterine environment.

Nozaki T, Fujimori H, Wang J, Suzuki H, Imai H, Watanabe M, Ohura K, Masutani M.

Pathol Int. 2013 Aug;63(8):408-14. doi: 10.1111/pin.12086.

PMID:
23957916
36.

Damage response of XRCC1 at sites of DNA single strand breaks is regulated by phosphorylation and ubiquitylation after degradation of poly(ADP-ribose).

Wei L, Nakajima S, Hsieh CL, Kanno S, Masutani M, Levine AS, Yasui A, Lan L.

J Cell Sci. 2013 Oct 1;126(Pt 19):4414-23. doi: 10.1242/jcs.128272. Epub 2013 Jul 18.

37.

PARG dysfunction enhances DNA double strand break formation in S-phase after alkylation DNA damage and augments different cell death pathways.

Shirai H, Poetsch AR, Gunji A, Maeda D, Fujimori H, Fujihara H, Yoshida T, Ogino H, Masutani M.

Cell Death Dis. 2013 Jun 6;4:e656. doi: 10.1038/cddis.2013.133.

38.

The H19 induction triggers trophoblast lineage commitment in mouse ES cells.

Fujimori H, Mukai H, Murakami Y, Hemberger M, Hippo Y, Masutani M.

Biochem Biophys Res Commun. 2013 Jun 28;436(2):313-8. doi: 10.1016/j.bbrc.2013.05.100. Epub 2013 Jun 4.

PMID:
23743205
39.

Poly(ADP-ribosyl)ation in carcinogenesis.

Masutani M, Fujimori H.

Mol Aspects Med. 2013 Dec;34(6):1202-16. doi: 10.1016/j.mam.2013.05.003. Epub 2013 May 25. Review.

PMID:
23714734
40.

Parg deficiency confers radio-sensitization through enhanced cell death in mouse ES cells exposed to various forms of ionizing radiation.

Shirai H, Fujimori H, Gunji A, Maeda D, Hirai T, Poetsch AR, Harada H, Yoshida T, Sasai K, Okayasu R, Masutani M.

Biochem Biophys Res Commun. 2013 May 24;435(1):100-6. doi: 10.1016/j.bbrc.2013.04.048. Epub 2013 Apr 23.

PMID:
23624507
41.

Poly(ADP-ribosylation) regulates chromatin organization through histone H3 modification and DNA methylation of the first cell cycle of mouse embryos.

Osada T, Rydén AM, Masutani M.

Biochem Biophys Res Commun. 2013 Apr 26;434(1):15-21. doi: 10.1016/j.bbrc.2013.03.074. Epub 2013 Mar 30.

PMID:
23548571
42.

The Arf/p53 protein module, which induces apoptosis, down-regulates histone H2AX to allow normal cells to survive in the presence of anti-cancer drugs.

Atsumi Y, Inase A, Osawa T, Sugihara E, Sakasai R, Fujimori H, Teraoka H, Saya H, Kanno M, Tashiro F, Nakagama H, Masutani M, Yoshioka K.

J Biol Chem. 2013 May 10;288(19):13269-77. doi: 10.1074/jbc.M112.402560. Epub 2013 Mar 27.

43.

Impact of post-procedural intravascular ultrasound findings on long-term results following self-expanding nitinol stenting in superficial femoral artery lesions.

Miki K, Fujii K, Fukunaga M, Kawasaki D, Shibuya M, Imanaka T, Tamaru H, Masutani M, Ohyanagi M, Masuyama T.

Circ J. 2013;77(6):1543-50. Epub 2013 Mar 7.

44.

Artemis-dependent DNA double-strand break formation at stalled replication forks.

Unno J, Takagi M, Piao J, Sugimoto M, Honda F, Maeda D, Masutani M, Kiyono T, Watanabe F, Morio T, Teraoka H, Mizutani S.

Cancer Sci. 2013 Jun;104(6):703-10. doi: 10.1111/cas.12144. Epub 2013 Apr 15.

45.

Rapid degradation of poly(ADP-ribose) after injection into the mouse bloodstream.

Okajima Y, Yoshida T, Fujimori H, Wang J, Harada H, Suzuki Y, Suzuki H, Masutani M.

Biol Pharm Bull. 2013;36(3):462-6.

46.

Arf and p53 act as guardians of a quiescent cellular state by protecting against immortalization of cells with stable genomes.

Osawa T, Atsumi Y, Sugihara E, Saya H, Kanno M, Tashiro F, Masutani M, Yoshioka K.

Biochem Biophys Res Commun. 2013 Mar 1;432(1):34-9. doi: 10.1016/j.bbrc.2013.01.091. Epub 2013 Jan 31.

PMID:
23376716
47.

Multiple complex coronary atherosclerosis in diabetic patients with acute myocardial infarction: a three-vessel optical coherence tomography study.

Fukunaga M, Fujii K, Nakata T, Shibuya M, Miki K, Kawasaki D, Masutani M, Kawabata-Lee M, Ohyanagi M, Masuyama T.

EuroIntervention. 2012 Dec 20;8(8):955-61. doi: 10.4244/EIJV8I8A145.

48.

Purification and visualization of encephalomyocarditisvirus synthesized by an in vitro protein expression system derived from mammalian cell extract.

Kobayashi T, Yukigai J, Ueda K, Machida K, Masutani M, Nishino Y, Miyazawa A, Imataka H.

Biotechnol Lett. 2013 Mar;35(3):309-14. doi: 10.1007/s10529-012-1086-1. Epub 2012 Nov 10.

PMID:
23143176
49.

Reconstitution of eukaryotic translation initiation factor 3 by co-expression of the subunits in a human cell-derived in vitro protein synthesis system.

Masutani M, Machida K, Kobayashi T, Yokoyama S, Imataka H.

Protein Expr Purif. 2013 Jan;87(1):5-10. doi: 10.1016/j.pep.2012.10.001. Epub 2012 Oct 11.

PMID:
23063735
50.

Induction of cancerous stem cells during embryonic stem cell differentiation.

Fujimori H, Shikanai M, Teraoka H, Masutani M, Yoshioka K.

J Biol Chem. 2012 Oct 26;287(44):36777-91. doi: 10.1074/jbc.M112.372557. Epub 2012 Sep 7.

Supplemental Content

Loading ...
Support Center